Contact Us
Please complete the form, and a representative of Intelligent Bio Solutions will contact you shortly to assist with your enquiry.
Our Locations
New York
Intelligent Bio Solutions Inc.
Floor 5, 135 W 41st St,
New York, NY 10036,
United States
+1 646 790 5756
Office Hours
9am – 5pm Monday to Friday
Sydney
Intelligent Bio Solutions Inc.
Level 1, Suite 5,
28-40 Lord Street,
Botany, NSW, 2019
Australia
Office Hours
9am – 5pm Monday to Friday
Cambridge
14-17 Evolution Business Park,
Milton Road, Impington,
Cambridge, CB24 9NG,
United Kingdom
info@intelligentfingerprinting.com
+44 (0)1223 941941
Office Hours
9am – 5pm Monday to Friday
Media Contact
For media enquiries, please contact marketing@ibs.inc.
Investor Contact
Valter Pinto, Managing Director
KCSA Strategic Communications
Find more information at investors.ibs.inc.
Connect With Us
Latest News
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
NEW YORK, June 4, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the Planet MicroCap Conference on June 16-18, 2026, in Las Vegas, NV. Conference Details Date: June 16-18, 2026 Location: Bellagio…
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
NEW YORK, June 02, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the initiation of a multi-site Method Comparison Study to support its FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for the…
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
NEW YORK, May 13, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results and operational highlights for the fiscal third quarter and nine months ended March 31, 2026, and provided a business update. “The third quarter marked…